循环线粒体DNA拷贝数可作为系统性红斑狼疮诊断及疾病活动度监测的敏感标志物
研究纳入103例连续系统性红斑狼疮(SLE)患者和56名健康献血者,用PCR定量血浆游离线粒体(mt)DNA和核(n)DNA拷贝数。SLE患者血浆mtDNA拷贝数较对照升高8.8倍,以1.8×10^7拷贝为界值诊断SLE的敏感度87.4%、特异度94.6%,曲线下面积0.95(p<0.0001);mtDNA与SLEDAI相关,33例随访者中mtDNA变化与SLEDAI演变相关(r=0.55,p=0.001),而nDNA无此关联。
要点
- SLE患者血浆mtDNA拷贝数中位数6.6×10^7/mL,对照为7.6×10^6/mL,升高8.8倍(p<0.0001)。
- 以1.8×10^7 mtDNA拷贝为界值诊断SLE,敏感度87.4%、特异度94.6%,曲线下面积0.95(p<0.0001)。
- 33例随访者中mtDNA变化与SLEDAI演变相关(r=0.55,p=0.001),nDNA无此相关。
核心结论
- SLE血浆中循环mtDNA而非nDNA分子显著增多,mtDNA水平无论疾病活动度如何均可高敏感度区分SLE与健康对照,并是SLE活动的独立标志物。
研究设计与样本
- 研究从103例连续SLE患者和56名健康献血者采集EDTA血浆,用PCR定量血浆游离mtDNA和nDNA拷贝数,并前瞻性记录临床参数。
主要发现
- SLE患者血浆循环mtDNA拷贝数较对照升高8.8倍(中位数6.6×10^7/mL vs 7.6×10^6/mL,p<0.0001)。
- 在全部159人中,以1.8×10^7 mtDNA拷贝为界值的受试者工作特征曲线识别SLE的敏感度为87.4%、特异度为94.6%,曲线下面积为0.95(p<0.0001)。
- mtDNA水平与年龄或性别无关,但在多变量分析中与系统性红斑狼疮疾病活动指数(SLEDAI)相关(p=0.004)。
- SLEDAI与泼尼松剂量(p<0.001)、抗双链DNA滴度(p=0.003)和mtDNA水平(p=0.005)相关,但与nDNA拷贝数无关。
- 在33例有随访资料的SLE患者中,mtDNA浓度变化而非nDNA浓度变化与SLEDAI演变显著相关(r=0.55,p=0.001)。
关键数值与推荐
- 以血浆mtDNA 1.8×10^7拷贝为界值诊断SLE:敏感度87.4%、特异度94.6%,曲线下面积0.95(p<0.0001)。
- 多变量分析中mtDNA水平与SLEDAI相关(p=0.004);SLEDAI与泼尼松剂量(p<0.001)、抗双链DNA滴度(p=0.003)及mtDNA水平(p=0.005)相关。
- 33例随访患者中mtDNA变化与SLEDAI演变相关(r=0.55,p=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cell-free DNA is involved in the pathogenesis of systemic lupus erythematosus (SLE) but the clinical value of cell-free DNA measurements in SLE is unknown. Our aim was therefore to examine the utility of mitochondrial (mt) DNA and nuclear (n) DNA quantification in SLE. METHODS: EDTA plasma was drawn from 103 consecutive patients with SLE and from 56 healthy blood donors. mtDNA and nDNA copy numbers were quantified by PCR from cell-free plasma. Clinical parameters were recorded prospectively. RESULTS: Circulating mtDNA copy numbers were increased 8.8-fold in the plasma of patients with SLE (median 6.6×107 /mL) compared with controls (median 7.6×106 /mL, p<0.0001). Among all 159 individuals, a cut-off set at 1.8×107 mtDNA copies in a receiver operated curve identified patients with SLE with 87.4% sensitivity and 94.6% specificity; the area under the curve was 0.95 (p<0.0001). mtDNA levels were independent of age or gender, but correlated with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) on multivariable analysis (p=0.004). Conversely, SLEDAI was associated with prednisone dose (p<0.001), anti-double stranded DNA-titres (p=0.003) and mtDNA levels (p=0.005), but not nDNA copy numbers. In 33 patients with SLE with available follow-up, the changes of mtDNA, but not those of nDNA concentrations, robustly correlated with the evolution of the SLEDAI (r=0.55, p=0.001). CONCLUSIONS: Circulating mtDNA unlike nDNA molecules are markedly increased in SLE plasma. Regardless of disease activity, circulating mtDNA levels distinguish patients with SLE from healthy controls with high sensitivity and represent an independent marker of SLE activity.
引用
- Giaglis S, Daoudlarian D, Voll RE, et al. Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus. RMD Open. 2021. PMID: 34916301. doi:10.1136/rmdopen-2021-002010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。